Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ibuprofen/Paracetamol vs Nuromol® in Healthy Subjects
NCT06180070Phase 1Completed
- Sponsor
- Humanis
- Start
- Aug 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acetaminophen + ibuprofen in migraine, Headache and low back pain (LBP) (2 arms), sponsored by Humanis. Primary endpoints: Maximum concentration obtained at 23 hours and AUC from time 0 to last collection time t at 23 hours. Started Aug 2023; status: completed.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
migraineHeadachelow back pain (LBP)
Beyond the preview
Go deeper on NCT06180070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06180070.